<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Polymers (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Polymers (Basel)</journal-id><journal-id journal-id-type="publisher-id">polymers</journal-id><journal-title-group><journal-title>Polymers</journal-title></journal-title-group><issn pub-type="epub">2073-4360</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006147</article-id><article-id pub-id-type="pmc">PMC11859971</article-id><article-id pub-id-type="doi">10.3390/polym17040485</article-id><article-id pub-id-type="publisher-id">polymers-17-00485</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Fabrication of Cellulose Derivatives-Based Highly Porous Floating Tablets for Gastroretentive Drug Delivery via Sugar Templating Method</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0530-4516</contrib-id><name><surname>Panraksa</surname><given-names>Pattaraporn</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-polymers-17-00485" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Chaiwarit</surname><given-names>Tanpong</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-polymers-17-00485" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5403-9830</contrib-id><name><surname>Chanabodeechalermrung</surname><given-names>Baramee</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-polymers-17-00485" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7498-8416</contrib-id><name><surname>Worajittiphon</surname><given-names>Patnarin</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af2-polymers-17-00485" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3598-1913</contrib-id><name><surname>Jantrawut</surname><given-names>Pensak</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-polymers-17-00485" ref-type="aff">1</xref><xref rid="c1-polymers-17-00485" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Nikolskaya</surname><given-names>Elena D.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Lomova</surname><given-names>Maria</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-polymers-17-00485"><label>1</label>Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand; <email>pattaraporn.pan@cmu.ac.th</email> (P.P.); <email>tanpong.ch@cmu.ac.th</email> (T.C.); <email>barameechana@gmail.com</email> (B.C.)</aff><aff id="af2-polymers-17-00485"><label>2</label>Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand; <email>patnarin.w@cmu.ac.th</email></aff><author-notes><corresp id="c1-polymers-17-00485"><label>*</label>Correspondence: <email>pensak.j@cmu.ac.th</email>; Tel.: +66-539-443-09</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>4</issue><elocation-id>485</elocation-id><history><date date-type="received"><day>11</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>31</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>06</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>This work presents an innovative application of the sugar templating method to fabricate highly porous floating tablets based on cellulose derivatives for gastroretentive drug delivery systems (GRDDS). Ethyl cellulose (EC) and hydroxypropyl methylcellulose (HPMC) were utilized to develop formulations that optimize porosity, buoyancy, and drug release. Among the tested formulations, E<sub>10</sub>H<sub>5</sub>/CPM, consisting of 10% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> EC and 5% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> HPMC loaded with chlorpheniramine maleate (CPM), exhibited the most favorable properties, including high porosity (94.4%), uniform pore distribution, immediate buoyancy, and over 24 h of floating time. E<sub>10</sub>H<sub>5</sub>/CPM tablets demonstrated superior drug release performance compared to an EC-only formulation (E<sub>10</sub>/CPM), attributed to the presence of HPMC, which facilitated improved hydration and diffusion. The <italic toggle="yes">in vitro</italic> release study showed that E<sub>10</sub>H<sub>5</sub>/CPM achieved a cumulative release of 79.01% over 72 h, following a Fickian diffusion mechanism. However, a limitation was noted in drug loading, with E<sub>10</sub>H<sub>5</sub>/CPM incorporating 6.40 mg of CPM, compared to 8.72 mg in E<sub>10</sub>/CPM. Future work should focus on enhancing drug load and further optimizing polymer composition to improve the release profile. Overall, this study underscores the potential of sugar templating in developing cost-effective, scalable floating tablet formulations for improved gastric retention and localized drug delivery.</p></abstract><kwd-group><kwd>floating drug delivery</kwd><kwd>ethyl cellulose</kwd><kwd>hydroxypropyl methylcellulose</kwd><kwd>sugar templating</kwd><kwd>microstructural analysis</kwd><kwd>cellulose-based formulations</kwd><kwd>controlled drug release</kwd></kwd-group><funding-group><award-group><funding-source>CMU Junior Research Fellowship Program</funding-source><award-id>JRCMU2567_011</award-id></award-group><funding-statement>This research project was supported by CMU Junior Research Fellowship Program, grant number JRCMU2567_011.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-polymers-17-00485"><title>1. Introduction</title><p>Gastroretentive drug delivery systems (GRDDS) have emerged as innovative drug delivery platforms designed to address the limitations of conventional oral drug delivery, such as poor bioavailability, fluctuating plasma drug levels, and inadequate drug release at the desired absorption site [<xref rid="B1-polymers-17-00485" ref-type="bibr">1</xref>,<xref rid="B2-polymers-17-00485" ref-type="bibr">2</xref>,<xref rid="B3-polymers-17-00485" ref-type="bibr">3</xref>]. By extending gastric retention time, GRDDS offer enhanced therapeutic outcomes, particularly for drugs with a narrow absorption window (e.g., levodopa, furosemide, riboflavin) [<xref rid="B4-polymers-17-00485" ref-type="bibr">4</xref>], those unstable in alkaline intestinal environments (e.g., verapamil, propranolol, diazepam) [<xref rid="B5-polymers-17-00485" ref-type="bibr">5</xref>,<xref rid="B6-polymers-17-00485" ref-type="bibr">6</xref>], or those requiring localized gastric delivery (e.g., ranitidine, or antibiotics for <italic toggle="yes">Helicobacter pylori</italic> eradication) [<xref rid="B7-polymers-17-00485" ref-type="bibr">7</xref>,<xref rid="B8-polymers-17-00485" ref-type="bibr">8</xref>]. Over the years, various types of GRDDS have been developed, including ion-exchange resin systems, magnetic systems, super-porous hydrogel systems, raft-forming systems, bioadhesive/mucoadhesive systems, expandable systems, high-density systems, and low-density/floating systems [<xref rid="B9-polymers-17-00485" ref-type="bibr">9</xref>]. Among these approaches, floating drug delivery systems (FDDS) stand out as a particularly promising option due to their unique combination of simplicity, non-invasive nature, effectiveness, and minimal physiological interference. FDDS achieve buoyancy by reducing the dosage form density, thereby maintaining prolonged gastric residence without complex structural modifications or external devices. In contrast, other GRDDS approaches, such as high-density systems, face manufacturing challenges due to the need for increased dosage form size to achieve high drug load and desired densities [<xref rid="B10-polymers-17-00485" ref-type="bibr">10</xref>], while magnetic systems generally rely on external devices that can hinder patient compliance and lead to practical challenges [<xref rid="B11-polymers-17-00485" ref-type="bibr">11</xref>]. Similarly, mucoadhesive systems often face limitations from mucus turnover, variability in mucus composition, and the risk of unintended esophageal adhesion [<xref rid="B12-polymers-17-00485" ref-type="bibr">12</xref>,<xref rid="B13-polymers-17-00485" ref-type="bibr">13</xref>]. These limitations highlight the need for practical and patient-friendly FDDS with consistent performance characteristics.</p><p>To date, the manufacturing of FDDS has leveraged diverse fabrication techniques. For instance, Oh et al. employed the sublimation method and camphor to create highly porous metformin tablets with extended buoyancy. However, they encountered challenges in maintaining tablet strength with increased camphor content [<xref rid="B14-polymers-17-00485" ref-type="bibr">14</xref>]. Similarly, Simons et al. utilized hot-melt extrusion (HME) to fabricate metformin FDDS in hollow tube forms, achieving immediate buoyancy dependent on the tube&#x02019;s outer-to-inner diameter ratio [<xref rid="B15-polymers-17-00485" ref-type="bibr">15</xref>]. More recently, additive manufacturing techniques, such as 3D and 4D printing, have been explored to design customizable FDDS with precise specifications [<xref rid="B16-polymers-17-00485" ref-type="bibr">16</xref>,<xref rid="B17-polymers-17-00485" ref-type="bibr">17</xref>,<xref rid="B18-polymers-17-00485" ref-type="bibr">18</xref>]. While these methods offer advanced control, they involve significant costs, longer production times, and specialized expertise, making them less accessible for small-scale healthcare providers and pharmacists.</p><p>To address these challenges, we introduced the sugar templating method as a novel, accessible approach for fabricating highly porous floating tablets. This method involves using sugar or similar materials (e.g., citric acid monohydrate and sodium chloride) as a sacrificial template to create porous structures [<xref rid="B19-polymers-17-00485" ref-type="bibr">19</xref>,<xref rid="B20-polymers-17-00485" ref-type="bibr">20</xref>,<xref rid="B21-polymers-17-00485" ref-type="bibr">21</xref>]. After the polymer matrix solidifies, the sugar is selectively removed through dissolution in water or an appropriate solvent, leaving behind a porous structure with interconnected pores mimicking the granular morphology of the template. This sugar-leaching process is critical to the technique, as it involves the careful removal of the sacrificial template without compromising the integrity of the surrounding polymer matrix, which retains its shape and structure. This simple, cost-effective, and environmentally friendly process has been widely employed in materials science. For example, Gonz&#x000e1;lez-Rivera et al. successfully fabricated highly porous polydimethylsiloxane (PDMS) foams using sugar templating, achieving interconnected 3D macrostructures with tunable pore sizes directly reflecting the sugar granule dimensions [<xref rid="B22-polymers-17-00485" ref-type="bibr">22</xref>]. Similarly, in our prior work, we applied the sugar templating method to develop ethyl cellulose (EC) sponges, which demonstrated high porosity and well-connected pore networks suitable for various applications [<xref rid="B23-polymers-17-00485" ref-type="bibr">23</xref>]. These studies underscore the versatility and potential of sugar templating in creating highly porous structures with tailored properties.</p><p>In this study, we extend the application of the sugar templating method to develop cellulose derivatives-based porous floating tablets for gastroretentive drug delivery, marking the first such application to our knowledge. Cellulose derivatives, such as EC and hydroxypropyl methylcellulose (HPMC), are widely utilized in pharmaceutical formulations due to their biocompatibility and favorable physicochemical properties. EC, a hydrophobic polymer, is water-insoluble but dissolves in organic solvents (e.g., alcohols, ketones, and aromatic hydrocarbons), forming robust matrices suitable for controlled drug release in gastric environments [<xref rid="B24-polymers-17-00485" ref-type="bibr">24</xref>]. Its insolubility in water ensures structural integrity during the sugar-leaching process, allowing for the selective removal of the sacrificial sugar template without compromising the polymer matrix and making it an ideal candidate as the main polymer for sugar-templating processes. HPMC, on the other hand, is a hydrophilic cellulose ether that swells in water, creating gel-like structures that enable drug release via diffusion and erosion mechanisms [<xref rid="B25-polymers-17-00485" ref-type="bibr">25</xref>]. The combination of these polymers allows fine-tuning of drug release profiles by adjusting the ratio of hydrophobic and hydrophilic components.</p><p>Overall, this study aimed to develop and evaluate cellulose derivative-based FDDS utilizing sugar templating to overcome the limitations of existing techniques. Highly porous floating tablets composed of EC and HPMC were fabricated, incorporating chlorpheniramine maleate (CPM) as a model drug. CPM, a widely used H<sub>1</sub>-receptor antagonist, is known for its synergistic effects with H<sub>2</sub>-receptor antagonists (e.g., famotidine) in reducing gastric inflammation and promoting ulcer healing [<xref rid="B26-polymers-17-00485" ref-type="bibr">26</xref>]. By prolonging gastric retention, the developed floating tablets could enhance the stability and efficacy of CPM in localized gastric treatment while reducing the dosing frequency, thereby improving patient compliance and therapeutic outcomes. The formulations were also evaluated for their morphological properties, mechanical strength, <italic toggle="yes">in vitro</italic> floatability, and drug release behavior to demonstrate their potential in gastroretentive drug delivery applications.</p></sec><sec id="sec2-polymers-17-00485"><title>2. Materials and Methods</title><sec id="sec2dot1-polymers-17-00485"><title>2.1. Materials</title><p>Ethyl cellulose (EC) powder with an ethoxy content of 48.6% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> was obtained from Sigma-Aldrich<sup>&#x000ae;</sup> (St. Louis, MO, USA). Hydroxypropyl methylcellulose E5 (HPMC E5, AnyCoat<sup>&#x000ae;</sup>-C AN5, substitution type 2910, viscosity 5 mPa&#x000b7;s) was purchased from Lotte Fine Chemical Co., Ltd. (Ulsan, Republic of Korea). Caster sugar (very fine granulated sugar) was purchased from Thai Roong Ruang Industry Co., Ltd. (Bangkok, Thailand). Acetone (&#x02265;99.5% purity) and 1 N hydrochloric acid (HCl) were purchased from RCI Labscan, Ltd. (Bangkok, Thailand), while ethanol (95.0%) was obtained from the Liquor Distillery Organization Thailand (Chachoengsao, Thailand). Chlorpheniramine maleate (CPM), used as the model drug in this study, was supplied by S. Tong Chemicals Co., Ltd. (Nonthaburi, Thailand). All other chemicals and reagents were of analytical grade.</p></sec><sec id="sec2dot2-polymers-17-00485"><title>2.2. Preparation of Floating Tablets</title><sec id="sec2dot2dot1-polymers-17-00485"><title>2.2.1. Design and Production of PDMS Tablet Molds</title><p>The tablet molds were designed with specific dimensions of 12.5 mm in diameter and 4.5 mm in thickness (<xref rid="polymers-17-00485-f001" ref-type="fig">Figure 1</xref>). These dimensions were chosen to ensure easy handling, particularly for elderly patients, while maintaining a size suitable for comfortable swallowing. These molds were fabricated by the Biomedical Engineering Institute of Chiang Mai University using a vat polymerization technique. Polydimethylsiloxane (PDMS) was used as the mold material and mixed with a curing agent in a 10:1 weight ratio. The mixture was cured at 70 &#x000b0;C for at least 2 h to achieve a durable and flexible mold. Once cured, the molds were thoroughly cleaned and prepared for use.</p></sec><sec id="sec2dot2dot2-polymers-17-00485"><title>2.2.2. Preparation of Sugar Tablet Templates</title><p>Sugar tablet templates were created by mixing caster sugar and distilled water in a ratio of 20:1 (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) to form a cohesive wet mass. The moistened sugar was then pressed into the PDMS molds to produce uniform sugar tablets with smooth surfaces (<xref rid="polymers-17-00485-f002" ref-type="fig">Figure 2</xref>a). Subsequently, the sugar-filled molds were oven-dried at 70 &#x000b0;C for 10 min. After drying, the sugar tablets (<xref rid="polymers-17-00485-f002" ref-type="fig">Figure 2</xref>b) were carefully removed from the molds to preserve their shape, ensuring they were suitable for subsequent fabrication steps.</p></sec><sec id="sec2dot2dot3-polymers-17-00485"><title>2.2.3. Fabrication of Floating Tablets Using the Sugar-Templating Method</title><p>The floating tablets in this study were fabricated using a sugar-templating approach. Initially, polymeric solutions were prepared by dispersing ethyl cellulose (EC) in acetone at varying concentrations, as detailed in <xref rid="polymers-17-00485-t001" ref-type="table">Table 1</xref>. The solutions were stirred continuously at 200 rpm at room temperature (25 &#x000b1; 2 &#x000b0;C) until homogeneous. In formulations containing hydroxypropyl methylcellulose (HPMC), EC was dispersed first, followed by the gradual addition of HPMC, with continuous stirring for 2 h or until the mixture was fully homogeneous. Next, the sugar tablet templates prepared in <xref rid="sec2dot2dot2-polymers-17-00485" ref-type="sec">Section 2.2.2</xref> (<xref rid="polymers-17-00485-f002" ref-type="fig">Figure 2</xref>b) were submerged in the EC or EC-HPMC mixtures and placed in a vacuum chamber for 10 min to remove air bubbles. The submerged templates were then left to stand for 2 h or until the polymeric mixtures had completely saturated the sugar tablets. Thereafter, the polymer-saturated sugar tablets were dried at 50 &#x000b1; 2 &#x000b0;C to evaporate the acetone. The evaporation process was facilitated by the porous structure of the tablets. Once dried, the tablets were soaked in distilled water for 24 h to leach out the sugar and remove any residual acetone, as acetone is completely miscible with water. Subsequently, the resulting wet EC or EC/HPMC tablets were dried again in a hot air oven at 50 &#x000b1; 2 &#x000b0;C to remove residual moisture. The water was periodically replaced throughout the process. These leaching and subsequent drying steps were repeated until the tablets reached a constant weight, ensuring the complete removal of residual water and acetone. Finally, all formulations were characterized to assess their morphology and identify those with optimal properties for drug loading and further analysis.</p></sec></sec><sec id="sec2dot3-polymers-17-00485"><title>2.3. Morphological Analysis for Pre-Screening of Floating Tablet Formulations</title><p>All cellulose derivative-based floating tablet formulations underwent morphological analysis to pre-screen suitable candidates for drug loading. This evaluation aimed to ensure the completeness of the internal microstructure and identify formulations with porosity consistent with the sugar template. Tablets with large or irregular pores, indicative of incomplete polymer infiltration, were excluded from further testing due to inadequate structural integrity.</p><p>Initial screening was performed using a digital portable USB mini-microscope (Yao, Shenzhen, China) with a built-in LED light source and a high-definition CMOS sensor. The microscope was positioned at fixed distances of 2.0 and 5.0 cm from the samples to maintain consistent imaging conditions. Cross-sectional images were captured using Windows 10 Camera software version 2024.2408.1.0 (Microsoft Corporation, Redmond, WA, USA). For detailed structural evaluation, microstructural analysis of the cross-sections was conducted using a benchtop scanning electron microscope (SEM, JCM-7000 NeoScope&#x02122;, JEOL Ltd., Tokyo, Japan). Before imaging, the tablets were halved to expose their cross-sections and mounted on aluminum stubs using double-sided conductive carbon tape (Nisshin EM Co., Ltd., Tokyo, Japan). The samples were gold-coated for 1 min using an automated sputter coater (JEOL Smart Coater, JEOL Ltd., Tokyo, Japan). SEM imaging was performed in a high vacuum with a secondary electron (SE) detector at an acceleration voltage of 15 kV and a magnification of &#x000d7;27. Formulations exhibiting a homogeneous structure with suitable pore formation and uniform pore distribution were selected for subsequent drug-loading studies.</p></sec><sec id="sec2dot4-polymers-17-00485"><title>2.4. Fabrication of Drug-Loaded Floating Tablets</title><p>Chlorpheniramine maleate (CPM) was incorporated into selected floating tablet formulations by adding 4% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> CPM to formulations E<sub>10</sub> and E<sub>10</sub>H<sub>5</sub>, which will hereafter be referred to as E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM, respectively. The fabrication process for these drug-loaded floating tablets followed the same procedure as previously described in <xref rid="sec2dot2dot2-polymers-17-00485" ref-type="sec">Section 2.2.2</xref> and <xref rid="sec2dot2dot3-polymers-17-00485" ref-type="sec">Section 2.2.3</xref>, with a slight modification to facilitate uniform drug dispersion. Specifically, CPM was first dissolved in acetone before the addition of EC to ensure homogeneous drug distribution within the polymeric matrix. The resulting drug-loaded tablets were subsequently characterized to evaluate drug incorporation, mechanical properties, floating performance, and drug release behavior.</p></sec><sec id="sec2dot5-polymers-17-00485"><title>2.5. Morphological Analysis of Drug-Loaded Floating Tablets</title><p>The morphology of the drug-loaded floating tablets was analyzed using the same methodology as described in <xref rid="sec2dot3-polymers-17-00485" ref-type="sec">Section 2.3</xref> to assess the effect of CPM incorporation on tablet structure. Cross-sectional imaging was conducted to compare the internal microstructure of drug-loaded formulations (E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM) with their non-drug-loaded formulations, evaluating any changes in pore distribution and overall tablet morphology.</p></sec><sec id="sec2dot6-polymers-17-00485"><title>2.6. Physical Characterization of Drug-Loaded Floating Tablets</title><p>To ensure batch uniformity, the drug-loaded tablets were evaluated for weight variation, diameter, thickness, and density as follows:</p><sec id="sec2dot6dot1-polymers-17-00485"><title>2.6.1. Weight Variation</title><p>Twenty tablets per formulation (n = 20) were individually weighed using an analytical balance with a readability of 0.1 mg (LAB 124i, Adam Equipment Co., Ltd., Milton Keynes, UK). The mean weight and standard deviation (SD) were calculated.</p></sec><sec id="sec2dot6dot2-polymers-17-00485"><title>2.6.2. Diameter and Thickness</title><p>Tablet diameter and thickness were measured using an electronic digital caliper with an accuracy of &#x000b1;0.01 mm (Becthai Bangkok Equipment &#x00026; Chemical Co., Ltd., Nakhon Pathom, Thailand). Measurements were taken at three different points on each tablet, and the average values were recorded.</p></sec><sec id="sec2dot6dot3-polymers-17-00485"><title>2.6.3. Tablet Density</title><p>The density (<inline-formula><mml:math id="mm1" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>) of the floating tablets was calculated using the following equation (Equation (1)) [<xref rid="B14-polymers-17-00485" ref-type="bibr">14</xref>]:<disp-formula id="FD1-polymers-17-00485"><label>(1)</label><mml:math id="mm2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mrow></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>&#x000d7;</mml:mo><mml:mi>&#x003c0;</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mi>h</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm3" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>W</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> is the tablet weight (g), <inline-formula><mml:math id="mm4" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> is the tablet diameter (cm), and <inline-formula><mml:math id="mm5" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> is the tablet thickness (cm).</p></sec></sec><sec id="sec2dot7-polymers-17-00485"><title>2.7. Porosity Analysis via Micro-CT Scan</title><p>The porosity and internal microstructure of the drug-loaded floating tablets were analyzed using a high-resolution micro-computed tomography (micro-CT) or x-ray computerized tomography scanner (SkyScan 1173, Bruker Corporation, Billerica, MA, USA). Scanning was performed at a voltage of 40 kV, a current of 100 &#x000b5;A, and a pixel resolution of 12.82 &#x000b5;m. A full 360&#x000b0; rotation of each sample was completed with a step size of 0.3&#x000b0;. Projection images were reconstructed into cross-sectional slices using NRecon software (version 1.6.9.18, Bruker Corporation). 3D models were generated using Dragonfly software (version 2024.1, Comet Technologies Canada Inc., Montr&#x000e9;al, QC, Canada) [<xref rid="B27-polymers-17-00485" ref-type="bibr">27</xref>] to visualize the structure and porosity inside the structure. Porosity quantification was performed using CTAn software (version 1.10, Bruker Corporation), which calculated open porosity percentages. Thresholding was applied to differentiate solid and void regions within the tablet structure. Additionally, radiodensity measurements of the drug-loaded floating tablets were obtained using Dragonfly software to further characterize their physical properties.</p></sec><sec id="sec2dot8-polymers-17-00485"><title>2.8. Mechanical Strength Testing of Drug-Loaded Floating Tablets</title><p>The mechanical strength testing of the floating tablets was evaluated using a texture analyzer (TA.XTplus, Stable Micro Systems Ltd., Surrey, UK), following methods adapted from Thapa et al. [<xref rid="B28-polymers-17-00485" ref-type="bibr">28</xref>] and Farias et al. [<xref rid="B29-polymers-17-00485" ref-type="bibr">29</xref>], with modifications in instrumentation and testing conditions. The test was conducted at room temperature (25 &#x000b1; 2 &#x000b0;C) using a 5 kg load cell and a 2 mm stainless steel cylindrical probe (P/2 probe). Before testing, the tablet diameter and thickness were measured using an electronic digital caliper. The texture analyzer operated in compression mode with a pre-test speed of 2.0 mm/s, a test speed of 1 mm/s until the probe penetrated 10 mm into the sponge-like structure of the tablet, and a post-test speed of 10 mm/s. The maximum force required for the probe to penetrate the tablet was recorded as the resistance force.</p><p>The radial tensile strength (<inline-formula><mml:math id="mm6" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) of the floating tablets was calculated using Equation (2) [<xref rid="B28-polymers-17-00485" ref-type="bibr">28</xref>]:<disp-formula id="FD2-polymers-17-00485"><label>(2)</label><mml:math id="mm7" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>&#x003c0;</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm8" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> represents the tensile strength (MPa), <inline-formula><mml:math id="mm9" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> is the maximum resistance force (N), <inline-formula><mml:math id="mm10" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> is the tablet diameter (mm), and <inline-formula><mml:math id="mm11" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> is the tablet thickness (mm).</p><p>All measurements were performed in quintuplicate (n = 5), and results were reported as mean &#x000b1; SD.</p></sec><sec id="sec2dot9-polymers-17-00485"><title>2.9. Determination of CPM Loading Content</title><p>The CPM content in the floating tablets was determined by dissolving three tablets from each formulation (E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM) individually in 10 mL of 95% <italic toggle="yes">v</italic>/<italic toggle="yes">v</italic> ethanol under magnetic stirring at 200 rpm and 25 &#x000b1; 2 &#x000b0;C for 2 h. Then, the resulting solution was diluted 20-fold with 95% ethanol, filtered through a 0.45 &#x000b5;m nylon syringe filter (Labfil<sup>&#x000ae;</sup>, Zhejiang Alwsci Technologies Co., Ltd., Hangzhou, China) and analyzed via UV-VIS spectrophotometry (UV-2600i, Shimadzu Corporation Kyoto, Japan) at a wavelength of 262.0 nm. The CPM content was quantified using a standard calibration curve, which was constructed for CPM in water over a concentration range of 5&#x02013;60 &#x000b5;g/mL. The calibration curve demonstrated linearity with a high correlation coefficient (R<sup>2</sup> = 0.9992). The linear regression equation obtained was <italic toggle="yes">y</italic> = 0.0147<italic toggle="yes">x</italic> &#x02212; 0.0368, where <italic toggle="yes">y</italic> represents absorbance and <italic toggle="yes">x</italic> corresponds to CPM concentration (&#x000b5;g/mL).</p></sec><sec id="sec2dot10-polymers-17-00485"><title>2.10. In Vitro Buoyancy Studies</title><p>The floating behavior of the CPM-loaded floating tablets (E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM) was evaluated using an <italic toggle="yes">in vitro</italic> buoyancy test, adapted from the method described by Nigusse et al. [<xref rid="B30-polymers-17-00485" ref-type="bibr">30</xref>], with modifications to align with the USP monograph for CPM tablet analysis [<xref rid="B31-polymers-17-00485" ref-type="bibr">31</xref>]. Each tablet was placed in a 100-mL beaker containing 100 mL of 0.01 N hydrochloric acid (HCl) as the dissolution medium. The medium was maintained at 37 &#x000b1; 0.5 &#x000b0;C and stirred at a rotation speed of 50 rpm. The floating lag time (i.e., the time required for the tablet to rise to the medium surface) and the total floating time (i.e., the time the tablet remained buoyant on the medium surface) were visually recorded.</p></sec><sec id="sec2dot11-polymers-17-00485"><title>2.11. In Vitro CPM Release Studies and Drug Release Kinetics</title><p>The drug release characteristics of the floating tablets were investigated under the same conditions as the <italic toggle="yes">in vitro</italic> buoyancy test. The dissolution study was conducted in a 100-mL beaker containing 100 mL of 0.01 N HCl, maintained at 37 &#x000b1; 0.5 &#x000b0;C, and stirred at 50 rpm using a magnetic stirrer. The experiment was conducted in triplicate, with 3 mL samples collected at predetermined time points (0.5, 1, 2, 3, 4, 5, 6, 7, 8, 12, 18, and 24 h) to monitor the drug release. After each sample withdrawal, an equal volume of fresh dissolution medium was added to maintain sink conditions. The collected samples were subsequently filtered using a 0.45 &#x000b5;m nylon syringe filter, diluted as necessary, and analyzed using a UV-VIS spectrophotometer (UV-2600i, Shimadzu Corporation, Kyoto, Japan) at &#x003bb;<sub>max</sub> of 264.0 nm. The amount of drug release at each time point was calculated based on a standard calibration curve derived from the absorbance-concentration relationship in 0.01 N HCl (<italic toggle="yes">y</italic> = 0.0211<italic toggle="yes">x</italic> &#x02212; 0.0241, R<sup>2</sup> = 0.9994, where <italic toggle="yes">y</italic> and <italic toggle="yes">x</italic> correspond to absorbance and CPM concentration (&#x000b5;g/mL), respectively). The results were graphically represented as cumulative drug release (%) over time (h).</p><p>To characterize the drug release mechanisms, the release data were fitted to various mathematical models, including zero-order, first-order, Higuchi, and Korsmeyer-Peppas (KP) models. The corresponding equations for each kinetic model are presented below (Equations (3)&#x02013;(6)):<disp-formula id="FD3-polymers-17-00485"><label>(3)</label><mml:math id="mm12" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtext>Zero-order</mml:mtext><mml:mo>&#x000a0;</mml:mo><mml:mi>model</mml:mi><mml:mo>:</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>&#x000b7;</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm13" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the amount of drug released at time <inline-formula><mml:math id="mm14" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="mm15" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the initial drug amount, and <inline-formula><mml:math id="mm16" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the zero-order rate constant.<disp-formula id="FD4-polymers-17-00485"><label>(4)</label><mml:math id="mm17" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtext>First-order</mml:mtext><mml:mo>&#x000a0;</mml:mo><mml:mi>model</mml:mi><mml:mo>:</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mo>&#x02061;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mo>&#x02061;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>&#x000b7;</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm18" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="mm19" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> represent the initial and released drug amount at time <inline-formula><mml:math id="mm20" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>, respectively, and <inline-formula><mml:math id="mm21" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the first-order rate constant.<disp-formula id="FD5-polymers-17-00485"><label>(5)</label><mml:math id="mm22" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Higuchi</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>model</mml:mi><mml:mo>:</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:mo>&#x000b7;</mml:mo><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm23" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the drug amount released at time <inline-formula><mml:math id="mm24" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="mm25" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the Higuchi diffusion constant.<disp-formula id="FD6-polymers-17-00485"><label>(6)</label><mml:math id="mm26" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Korsmeyer</mml:mi><mml:mo>&#x02013;</mml:mo><mml:mi>Peppas</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>model</mml:mi><mml:mo>:</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x0221e;</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>&#x000b7;</mml:mo><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm27" overflow="scroll"><mml:mrow><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x0221e;</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mrow></mml:math></inline-formula> represents the fraction of drug released at time <inline-formula><mml:math id="mm28" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="mm29" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is a constant related to the structural and geometric properties of the dosage form, and <inline-formula><mml:math id="mm30" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> is the release exponent.</p></sec><sec id="sec2dot12-polymers-17-00485"><title>2.12. Statistical Analysis</title><p>All data are presented as mean &#x000b1; standard deviation (SD). Statistical analyses were performed using one-way analysis of variance (ANOVA) with SPSS<sup>&#x000ae;</sup> Statistics software version 17.0 (IBM Corporation, Armonk, NY, USA). A <italic toggle="yes">p</italic>-value &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec3-polymers-17-00485"><title>3. Results and Discussion</title><sec id="sec3dot1-polymers-17-00485"><title>3.1. Morphological Analysis of Cellulose Derivative-Based Floating Tablets</title><p>The morphological characteristics of cellulose derivative-based floating tablets were examined using both digital microscopy and SEM to evaluate their internal structure, with a focus on porosity, uniformity, and pore size distribution. Cross-sectional SEM images of the floating tablets (<xref rid="polymers-17-00485-f003" ref-type="fig">Figure 3</xref>) revealed notable differences in pore structures among the various formulations, primarily influenced by the concentrations of EC and HPMC in the polymeric mixtures. Despite these variations, all tablets exhibited a highly porous and sponge-like structure, which is crucial for maintaining buoyancy.</p><p>In formulations containing only EC (<xref rid="polymers-17-00485-f003" ref-type="fig">Figure 3</xref>a), pore structures varied significantly based on polymer concentration. At low EC concentrations (E<sub>7.5</sub>), the tablets exhibited large and irregular hollow regions, likely due to insufficient polymer content to fully form a stable matrix. Conversely, at very high EC concentrations (E<sub>12.5</sub> and E<sub>15</sub>), the tablets displayed elongated hollow channels and irregularly shaped large pores, potentially resulting from the high viscosity of the polymeric solution. The high viscosity likely hindered the effective infiltration of polymeric solution into the sugar template, leading to incomplete pore formation. This observation is consistent with the findings by Prasanthi et al. [<xref rid="B32-polymers-17-00485" ref-type="bibr">32</xref>], which found that highly viscous liquids tended to diffuse less effectively into porous structures, resulting in reduced infiltration efficiency compared to lower-viscosity liquids. Similarly, in this study, the elevated viscosity of the EC solutions hindered complete infiltration into the sugar template, thereby affecting the uniformity and quality of the pore network. Notably, E<sub>10</sub> exhibited the smallest and most uniform pore distribution, indicating an optimal balance between solution viscosity and template infiltration. These findings highlight that both excessively low and excessively high EC concentrations resulted in suboptimal morphology.</p><p>The addition of HPMC to the formulations significantly influenced the internal morphology of the tablets. Formulations containing 5% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> HPMC (<xref rid="polymers-17-00485-f003" ref-type="fig">Figure 3</xref>b) exhibited a more homogeneous pore distribution compared to EC-only formulations. Among these, E<sub>10</sub>H<sub>5</sub> demonstrated a well-defined and uniform pore structure, suggesting that the synergistic effects of EC and HPMC enhanced the polymeric network. This enhancement can be attributed to the ability of EC and HPMC to form hydrogen bonds and hydrophobic interactions. EC, being relatively hydrophobic, interacted with the hydrophobic regions of HPMC, while hydroxyl groups in both polymers enabled hydrogen bonding [<xref rid="B33-polymers-17-00485" ref-type="bibr">33</xref>]. These interactions likely contributed to the formation of a more cohesive and stable polymer matrix, thus improving pore uniformity and structural integrity. However, when the HPMC content increased to 7.5% (E<sub>7.5</sub>H<sub>7.5</sub>, E<sub>10</sub>H<sub>7.5</sub>, E<sub>12.5</sub>H<sub>7.5</sub>, and E<sub>15</sub>H<sub>7.5</sub>), the SEM images (<xref rid="polymers-17-00485-f003" ref-type="fig">Figure 3</xref>c) revealed larger hollow cavities and more irregular pores. These changes could be attributed to the increased viscosity of the EC-HPMC mixture, which reduced the efficiency of polymer infiltration into the sugar template. Additionally, the high viscosity may have exerted a physical force on the sugar particles during the soaking process, disrupting their arrangement and resulting in wider pore spacing. Similar disruptions in pore uniformity were also reported by Oh et al. in a study where templating systems were fabricated using highly viscous polymeric solutions [<xref rid="B34-polymers-17-00485" ref-type="bibr">34</xref>]. Moreover, the excessive HPMC content likely increased the matrix&#x02019;s hydrophilicity, which influenced pore formation during the sugar-leaching and drying processes. Since HPMC is highly hydrophilic, it may have absorbed and retained more water during the sugar-leaching step, causing the polymeric network to swell. This swelling could have disrupted the pore uniformity, leading to the formation of larger and more irregular pores during drying as the absorbed water evaporated [<xref rid="B35-polymers-17-00485" ref-type="bibr">35</xref>]. Rapid moisture removal during drying may have also caused structural shrinkage or deformation [<xref rid="B36-polymers-17-00485" ref-type="bibr">36</xref>], further contributing to the inconsistent porous morphology observed in formulations with 7.5% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> HPMC. These findings underscore the importance of balancing HPMC content to maintain a desirable pore structure and ensure structural stability.</p><p>Based on these results, E<sub>10</sub> and E<sub>10</sub>H<sub>5</sub> were selected for drug loading and further study due to their well-defined and fully porous structures achieved through sugar templating, indicating their potential for optimized drug delivery performance.</p></sec><sec id="sec3dot2-polymers-17-00485"><title>3.2. Impact of CPM Incorporation on Tablet Morphology</title><p>The incorporation of CPM into the selected floating tablet formulations (E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM) caused subtle yet significant changes in pore morphology. Cross-sectional SEM images of the drug-loaded formulations (<xref rid="polymers-17-00485-f004" ref-type="fig">Figure 4</xref>) revealed slightly reduced pore sizes compared to their non-drug-loaded formulations. The reduction likely occurred because CPM occupied pore spaces or altered the polymeric matrix during solvent evaporation. Specifically, as acetone evaporated during drying, CPM molecules may have precipitated within the polymeric network, creating additional solid material that partially filled or narrowed the pores. This result aligns with previous publications that demonstrated decreased porosity when additional compounds, such as graphene, were incorporated into polymeric matrices. Earlier work on PDMS foams reported a reduction in porosity with increasing graphene content, with a significant decrease observed at 30% graphene concentration. Similarly, our findings suggested that CPM incorporation led to a denser tablet structure due to reduced pore size [<xref rid="B37-polymers-17-00485" ref-type="bibr">37</xref>]. In addition, macroscopic images of the floating tablets in <xref rid="app1-polymers-17-00485" ref-type="app">Figure S1</xref> confirmed that the overall size of the fabricated floating tablets was consistent with the sugar tablet template used during preparation. The uniform dimensions of the tablets, as shown in both images, suggested precise replication of the template mold, ensuring consistency across different batches. This observation further supported the structural integrity and reliability of the templating method used in this study.</p></sec><sec id="sec3dot3-polymers-17-00485"><title>3.3. Physical and Microstructural Characteristics of Drug-Loaded Floating Tablets</title><p>The physical and microstructural characteristics of drug-loaded floating tablets are critical parameters influencing the overall performance of a floating drug delivery system. In this study, formulations E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM were evaluated for their physical properties, including weight, diameter, thickness, density and porosity, with results summarized in <xref rid="polymers-17-00485-t002" ref-type="table">Table 2</xref>.</p><p>Significant differences in tablet weight were observed between the formulations. E<sub>10</sub>/CPM had an average weight of 39.93 &#x000b1; 0.25 mg, whereas E<sub>10</sub>H<sub>5</sub>/CPM was significantly heavier at 50.40 &#x000b1; 3.69 mg (<italic toggle="yes">p</italic> &#x0003c; 0.05). The higher weight of E<sub>10</sub>H<sub>5</sub>/CPM can be attributed to the presence of 5% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> HPMC, which increased the polymer content within the matrix. Furthermore, the observed variation in tablet weight between E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM suggested differences in polymer deposition on the tablet surface and infiltration ability into the internal structure of the sugar template. Since E<sub>10</sub>H<sub>5</sub>/CPM contained a blend of EC and HPMC, its polymeric solution had a higher viscosity compared to the EC-only formulation (E<sub>10</sub>/CPM). This increased viscosity likely resulted in a thicker polymer coating on the tablet surface while also allowing some degree of polymer penetration into the internal porous network of sugar template.</p><p>Micro-CT 3D imaging (<xref rid="polymers-17-00485-f005" ref-type="fig">Figure 5</xref>) further supports these findings, illustrating distinct differences in surface coating and internal polymer distribution between the two formulations. The E<sub>10</sub>H<sub>5</sub>/CPM tablets appeared to have a denser polymeric layer on the exterior while also showing evidence of polymer infiltration into the internal pores, which may have contributed to their higher density (0.095 &#x000b1; 0.010 g/cm<sup>3</sup>) compared to E<sub>10</sub>/CPM (0.079 &#x000b1; 0.003 g/cm<sup>3</sup>). In contrast, the E<sub>10</sub>/CPM tablets exhibited a less compact polymer network and a more open structure, explaining their lower density and reduced mass. The micro-CT images also indicate that the surface of E<sub>10</sub>/CPM tablets was less tightly packed compared to HPMC-containing formulations, further emphasizing the impact of polymer composition on tablet morphology. Additionally, open porosity measurements from micro-CT scans revealed significant differences between the two formulations, with E<sub>10</sub>H<sub>5</sub>/CPM exhibiting a porosity of 94.4% compared to 93.6% for E<sub>10</sub>/CPM. The higher open porosity of E<sub>10</sub>H<sub>5</sub>/CPM aligned with its denser polymer network, which likely facilitated better interconnectivity of pores during the sugar-leaching step.</p><p>In addition to porosity analysis, radiodensity measurements were conducted to further characterize the microstructure of the floating tablets. The obtained radiodensity values were &#x02212;950.03 Hounsfield Units (HU) for E<sub>10</sub>/CPM and &#x02212;943.76 HU for E<sub>10</sub>H<sub>5</sub>/CPM. These findings indicate that both formulations possessed highly porous structures, as negative radiodensity values (&#x0003c;0 HU) suggested air-filled voids within the matrix [<xref rid="B38-polymers-17-00485" ref-type="bibr">38</xref>,<xref rid="B39-polymers-17-00485" ref-type="bibr">39</xref>]. These results align with the observed density and micro-CT image data, where E<sub>10</sub>H<sub>5</sub>/CPM exhibited slightly denser structure compared to E<sub>10</sub>/CPM. This correlation further highlights the impact of polymer composition on the structural properties of the floating tablets.</p><p>Similarly, the tablet thickness followed a comparable trend, with E<sub>10</sub>H<sub>5</sub>/CPM (4.39 &#x000b1; 0.14 mm) being slightly thicker than E<sub>10</sub>/CPM (4.30 &#x000b1; 0.16 mm). Although the difference was not statistically significant, it suggested that the presence of HPMC contributed to a marginal increase in structural volume, likely due to the polymer&#x02019;s ability to swell upon hydration during the sugar-leaching step. Compared to the original sugar template thickness (4.51 &#x000b1; 0.12 mm), both formulations showed slight shrinkage, with E<sub>10</sub>/CPM exhibiting a more noticeable reduction due to its less dense polymer matrix.</p><p>In terms of tablet diameter, both formulations closely matched the diameter of the original sugar template (12.19 &#x000b1; 0.02 mm), with E<sub>10</sub>/CPM having a diameter of 12.23 &#x000b1; 0.04 mm and E<sub>10</sub>H<sub>5</sub>/CPM slightly larger at 12.43 &#x000b1; 0.08 mm. This slight increase in diameter for E<sub>10</sub>H<sub>5</sub>/CPM was consistent with its higher polymer content, which contributed to a thicker coating and a marginally larger tablet size.</p></sec><sec id="sec3dot4-polymers-17-00485"><title>3.4. Mechanical Strength of Drug-Loaded Floating Tablets</title><p>The mechanical strength of the drug-loaded floating tablets was evaluated to assess their durability during handling and their potential to withstand mechanical stresses in the gastrointestinal environment. Radial tensile strength (<inline-formula><mml:math id="mm31" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) values for E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM formulations are presented in <xref rid="polymers-17-00485-t003" ref-type="table">Table 3</xref>. The results showed that E<sub>10</sub>H<sub>5</sub>/CPM tablets exhibited significantly higher tensile strength (0.156 &#x000b1; 0.004 MPa) compared to E<sub>10</sub>/CPM tablets (0.143 &#x000b1; 0.045 MPa) (<italic toggle="yes">p</italic> &#x0003c; 0.05). This increase in tensile strength for E<sub>10</sub>H<sub>5</sub>/CPM may be attributed to the presence of HPMC, which enhanced the structural integrity of the polymer matrix by increasing polymer-polymer interactions and forming a more cohesive network. The reduced pore size, as discussed in <xref rid="sec3dot2-polymers-17-00485" ref-type="sec">Section 3.2</xref>, likely also contributed to the higher mechanical strength by decreasing void volume and increasing the effective solid content of the tablets. These findings align well with a previous study by Freag et al. [<xref rid="B40-polymers-17-00485" ref-type="bibr">40</xref>], which developed buccal chitosan-based composite sponges. Their results demonstrated that the incorporation of HPMC into the formulations improved mechanical properties and increased the hardness of the chitosan sponges.</p><p>Generally, a tensile strength greater than 1.7 MPa is considered sufficient to ensure that a tablet is mechanically robust enough for manufacture and distribution [<xref rid="B41-polymers-17-00485" ref-type="bibr">41</xref>,<xref rid="B42-polymers-17-00485" ref-type="bibr">42</xref>]. However, in this study, the observed tensile strengths for both formulations were considerably lower than this threshold. This low tensile strength was likely due to their highly porous and sponge-like structure, which was specifically designed to enhance buoyancy and prolong gastric retention via floating. Such structural characteristics allow easy penetration by the texture analyzer probe, leading to lower tensile strength values. Similar trends have been observed in sponge-like wound dressings and other porous drug delivery systems, where increased porosity often resulted in reduced mechanical strength [<xref rid="B43-polymers-17-00485" ref-type="bibr">43</xref>,<xref rid="B44-polymers-17-00485" ref-type="bibr">44</xref>]. Our results are consistent with a previous study on sponge-like dressings, which exhibited comparable mechanical properties (approximately 0.07&#x02013;0.20 MPa) [<xref rid="B45-polymers-17-00485" ref-type="bibr">45</xref>]. This similarity suggests that such tensile strength values are characteristic and normal for sponge-like structures. To enhance mechanical robustness of the highly porous tablets, future studies could explore the incorporation of cross-linking agents such as boric acid to reinforce polymeric interactions [<xref rid="B46-polymers-17-00485" ref-type="bibr">46</xref>]. Alternatively, blending EC with polymers such as methacrylic derivatives or Kollidon<sup>&#x000ae;</sup> SR (a blend of polyvinyl acetate and PVP K30 in an 8:2 ratio) may help improve tensile strength [<xref rid="B47-polymers-17-00485" ref-type="bibr">47</xref>,<xref rid="B48-polymers-17-00485" ref-type="bibr">48</xref>]. While the low tensile strength observed in this study may limit the tablets&#x02019; ability to withstand high mechanical stress, it is unlikely to affect their practical use by patients if appropriate precautions are taken. To mitigate potential issues during handling and transportation, special packaging such as blister packs or individually compartmentalized containers should be employed. Such packaging can help protect the tablets from excessive mechanical forces, thereby ensuring their integrity until use.</p></sec><sec id="sec3dot5-polymers-17-00485"><title>3.5. Drug Loading Content</title><p>The CPM loading content in the floating tablets was determined to assess the efficiency of drug incorporation. As shown in <xref rid="polymers-17-00485-t003" ref-type="table">Table 3</xref>, E<sub>10</sub>/CPM exhibited a CPM loading content of 8.72 &#x000b1; 0.53 mg, whereas E<sub>10</sub>H<sub>5</sub>/CPM had a significantly lower loading of 6.40 &#x000b1; 0.22 mg (<italic toggle="yes">p</italic> &#x0003c; 0.05). These drug amounts are sufficient to reduce the frequency of CPM administration, where the typical dose of CPM is 4 mg every 4&#x02013;6 h. The lower drug content in E<sub>10</sub>H<sub>5</sub>/CPM may be attributed to the presence of HPMC, which potentially influenced drug retention within the polymer matrix. One possible explanation is that a portion of the CPM may have dissolved in water during the sugar-leaching step rather than being fully retained within the polymer network. Despite this, a substantial amount of CPM remained entrapped in the polymer matrix due to the hydrophobic nature of EC, which restricted drug diffusion into water. Additionally, solvent evaporation likely promoted CPM precipitation within the matrix [<xref rid="B49-polymers-17-00485" ref-type="bibr">49</xref>,<xref rid="B50-polymers-17-00485" ref-type="bibr">50</xref>], further minimizing drug loss. Since CPM is highly water-soluble (&#x0003e;100 mg/mL) [<xref rid="B51-polymers-17-00485" ref-type="bibr">51</xref>], some degree of loss was anticipated during sugar-leaching. However, the narrow SD values in drug content analysis suggest that any drug loss was consistent across batches and did not introduce significant variability in drug content. These findings support the reproducibility of the manufacturing process and highlight the importance of optimizing polymer composition to maximize drug retention within floating tablets. To address potential drug loss, we optimized the leaching process by using the shortest possible time while ensuring complete removal of the sugar. This approach aimed to minimize unnecessary exposure to water, thereby reducing CPM dissolution and loss. Future studies may explore the incorporation of poorly water-soluble drugs, which could further reduce drug loss during sugar-leaching and improve drug retention within the matrix while maintaining the desired porous structure for floating and controlled drug release. This strategy could also contribute to extending dosing intervals, thereby enhancing therapeutic efficacy.</p></sec><sec id="sec3dot6-polymers-17-00485"><title>3.6. Floating Behavior of Drug-Loaded Floating Tablets</title><p>The floating behavior of the drug-loaded tablets was evaluated to determine their suitability for prolonged gastric retention. Both E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM demonstrated an immediate floating lag time of 0 min, indicating their ability to float upon contact with the dissolution medium. Additionally, both formulations exhibited a total floating duration exceeding 24 h, confirming their potential for extended gastric retention. The prolonged floating time can be attributed to the highly porous structure of the tablets, which effectively trapped air within the matrix, allowing them to remain buoyant. Furthermore, despite the slightly higher density of E<sub>10</sub>H<sub>5</sub>/CPM, its floating performance remained uncompromised, likely because its density was still lower than that of gastric fluid (1.004 g/cm<sup>3</sup>) [<xref rid="B52-polymers-17-00485" ref-type="bibr">52</xref>,<xref rid="B53-polymers-17-00485" ref-type="bibr">53</xref>]. This suggests that the polymeric composition maintained a balance between structural integrity and buoyancy. These findings indicate that the developed floating tablets possess excellent floating properties, making them suitable candidates for GRDDS.</p></sec><sec id="sec3dot7-polymers-17-00485"><title>3.7. In Vitro CPM Release Profiles and Release Kinetics</title><p>The <italic toggle="yes">in vitro</italic> drug release profiles of the floating tablets (E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM) were investigated to evaluate their sustained-release behavior and assess the impact of polymer composition on drug release kinetics. The results revealed distinct differences between the two formulations in terms of cumulative drug release over time (<xref rid="polymers-17-00485-f006" ref-type="fig">Figure 6</xref>). The floating tablets containing only EC (E<sub>10</sub>/CPM) exhibited a markedly slower release rate compared to the HPMC-containing formulation (E<sub>10</sub>H<sub>5</sub>/CPM). At 72 h, E<sub>10</sub>/CPM released only 26.30 &#x000b1; 2.31% of the drug, whereas E<sub>10</sub>H<sub>5</sub>/CPM achieved a substantially higher release of 79.01 &#x000b1; 5.68%. These findings highlight the influence of HPMC on the release characteristics of the floating tablets. The limited drug release observed in the E<sub>10</sub>/CPM formulation can be attributed to the hydrophobic nature of EC [<xref rid="B54-polymers-17-00485" ref-type="bibr">54</xref>], which serves as the main polymer in the matrix. EC creates a barrier that hinders the penetration of the dissolution medium into the tablet, thereby slowing the diffusion of CPM. Consequently, the drug release is prolonged but incomplete. In contrast, the addition of 5% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> HPMC in the E<sub>10</sub>H<sub>5</sub>/CPM formulation significantly altered the release behavior. HPMC is a hydrophilic polymer that absorbs water and swells upon exposure to the dissolution medium, forming a gel-like layer on the tablet surface. This gel layer enhances matrix hydration and provides channels for the diffusion of CPM, leading to more efficient and sustained drug release [<xref rid="B55-polymers-17-00485" ref-type="bibr">55</xref>]. The presence of HPMC thus counterbalances the hydrophobic effect of EC, facilitating improved drug release. These findings are consistent with the findings of Yang et. al. [<xref rid="B54-polymers-17-00485" ref-type="bibr">54</xref>], who fabricated tablets via 3D printing using EC as the main polymer and investigated the influence of release modifiers (e.g., HPMC, sodium alginate (SA)) on drug release behavior. Their study demonstrated that without release modifiers, drug release through the matrix was limited (17.8% in 24 h). However, when HPMC and SA were added as release modifiers, the drug release within 24 h increased significantly to 83.0% and 80.3%, respectively. This underscores the critical role of hydrophilic additives in overcoming the limitations of hydrophobic matrices and enhancing drug release efficiency.</p><p>The release mechanisms of these formulations were further investigated by fitting the release data to various mathematical models, including zero-order, first-order, Higuchi, and Korsmeyer-Peppas models. The best-fitting model for each formulation was identified based on the highest regression coefficient (R<sup>2</sup>) values, as presented in <xref rid="polymers-17-00485-t004" ref-type="table">Table 4</xref>. The results indicated that the release kinetics of E<sub>10</sub>/CPM were best described by the zero-order model (R<sup>2</sup> = 0.9901) and the Korsmeyer-Peppas model (R<sup>2</sup> = 0.9900, <inline-formula><mml:math id="mm32" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> = 0.64). The zero-order model, characterized by a constant release rate over time, suggests that the hydrophobic EC matrix provided a controlled-release system that maintained steady drug release. Furthermore, the Korsmeyer-Peppas model revealed an <inline-formula><mml:math id="mm33" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> value of 0.64, indicating an anomalous transport mechanism, where drug release was controlled by a combination of diffusion and matrix relaxation, with minor swelling of the hydrophobic polymer [<xref rid="B56-polymers-17-00485" ref-type="bibr">56</xref>,<xref rid="B57-polymers-17-00485" ref-type="bibr">57</xref>]. For the E<sub>10</sub>H<sub>5</sub>/CPM formulation, the release kinetics were best described by the Korsmeyer-Peppas model (R<sup>2</sup> = 0.9959, <inline-formula><mml:math id="mm34" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> = 0.40). The <inline-formula><mml:math id="mm35" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> value of 0.40 in the Korsmeyer-Peppas model indicated that the drug release followed a Fickian diffusion mechanism, where CPM molecules diffused through the hydrated polymer matrix in response to a concentration gradient [<xref rid="B58-polymers-17-00485" ref-type="bibr">58</xref>,<xref rid="B59-polymers-17-00485" ref-type="bibr">59</xref>]. This was further supported by its excellent fit to the Higuchi model (R<sup>2</sup> = 0.9877), which is characteristic of diffusion-controlled release systems. The enhanced drug release observed in E<sub>10</sub>H<sub>5</sub>/CPM can thus be attributed to the improved diffusion pathways created by the hydrophilic and swellable HPMC within the matrix.</p><p>Overall, the release profiles of E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM demonstrated the impact of polymer composition on the drug release mechanism. E<sub>10</sub>/CPM exhibited a controlled release with a predominantly diffusion- and relaxation-based mechanism, while E<sub>10</sub>H<sub>5</sub>/CPM facilitated a more efficient release through Fickian diffusion, largely due to the hydrophilic and swelling properties of HPMC. These findings highlight the importance of selecting appropriate polymers to modulate the release kinetics and enhance the therapeutic efficacy of floating tablet formulations.</p></sec></sec><sec sec-type="conclusions" id="sec4-polymers-17-00485"><title>4. Conclusions</title><p>This study highlights the potential of the sugar templating method as an effective and sustainable approach for fabricating highly porous floating tablets using cellulose derivatives. The optimized E<sub>10</sub>H<sub>5</sub>/CPM formulation exhibited superior performance in terms of porosity (94.4%), immediate buoyancy, and extended floating time (&#x0003e;24 h), making it a promising candidate for GRDDS. The mechanical strength evaluation indicated that the incorporation of 5% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> HPMC enhanced structural integrity, as evidenced by a higher tensile strength (0.156 MPa) compared to EC-only formulations. Moreover, the addition of HPMC significantly improved the drug release profile, enabling 79.01% of the loaded CPM to be released over 72 h. Micro-CT imaging further confirmed the homogeneity of the pore structure, which played a crucial role in maintaining buoyancy and controlled drug release of the developed formulation. While the formulation successfully achieved prolonged floating and sustained release, a slight reduction in drug loading capacity (6.40 mg in E<sub>10</sub>H<sub>5</sub>/CPM vs. 8.72 mg in E<sub>10</sub>/CPM) was observed. These findings underscore the need for further optimization in polymer composition or alternative solvent systems (e.g., aqueous-organic solvent mixtures) to maximize drug entrapment efficiency. While sugar templating offers a simpler and more cost-effective approach compared to other manufacturing techniques, its scalability requires further investigation. To achieve industrial feasibility, key parameters such as the uniformity of sugar templates, the efficiency of sugar leaching, and the robustness of the polymer matrix must be optimized. Additionally, developing a continuous manufacturing process or integrating this method with existing pharmaceutical production lines could enhance its applicability. A further study on direct comparison with other novel manufacturing techniques (e.g., 3D printing and hot-melt extrusion) is also essential to evaluate the advantages and limitations of sugar templating in terms of drug release control, mechanical properties, and manufacturing feasibility. Additionally, future research should also focus on exploring the incorporation of poorly water-soluble drugs to further reduce drug loss and improve drug loading efficiency, as well as conducting <italic toggle="yes">in vivo</italic> studies to validate the clinical applicability of these formulations and assess their pharmacokinetic performance.</p></sec></body><back><ack><title>Acknowledgments</title><p>This research was supported by CMU Junior Research Fellowship Program, Chiang Mai University. The authors would like to express heartfelt gratitude to Tawanporn Chanta, Thanapoom Detupakarn, Chattarin Sapso, Natthanicha Sukprapaporn, Pran Thamvivornkul, and Saktiyaphong Paowan for their invaluable assistance in conducting the experiments for this study.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-polymers-17-00485"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/polym17040485/s1">https://www.mdpi.com/article/10.3390/polym17040485/s1</uri>, Figure S1: Macroscopic images of (a) E<sub>10</sub>/CPM and (b) E<sub>10</sub>H<sub>5</sub>/CPM.</p><supplementary-material id="polymers-17-00485-s001" position="float" content-type="local-data"><media xlink:href="polymers-17-00485-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, P.P., T.C. and P.J.; methodology, P.P., T.C., P.W. and P.J.; formal analysis, P.P., T.C., B.C. and P.J.; investigation, P.P., T.C., B.C. and P.J.; resources, P.W.; writing&#x02014;original draft preparation, P.P., T.C., P.W. and P.J.; writing&#x02014;review and editing, P.P., T.C. and P.J.; visualization, P.P.; supervision, P.J.; project administration, P.P. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Dataset available on request from the authors.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-polymers-17-00485"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parikh</surname><given-names>D.C.</given-names></name>
<name><surname>Amin</surname><given-names>A.F.</given-names></name>
</person-group><article-title>In Vitro and in Vivo Techniques to Assess the Performance of Gastro-Retentive Drug Delivery Systems: A Review</article-title><source>Expert Opin. Drug Deliv.</source><year>2008</year><volume>5</volume><fpage>951</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1517/17425247.5.9.951</pub-id><pub-id pub-id-type="pmid">18754747</pub-id>
</element-citation></ref><ref id="B2-polymers-17-00485"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mandal</surname><given-names>U.K.</given-names></name>
<name><surname>Chatterjee</surname><given-names>B.</given-names></name>
<name><surname>Senjoti</surname><given-names>F.G.</given-names></name>
</person-group><article-title>Gastro-Retentive Drug Delivery Systems and Their in Vivo Success: A Recent Update</article-title><source>Asian J. Pharm. Sci.</source><year>2016</year><volume>11</volume><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/j.ajps.2016.04.007</pub-id></element-citation></ref><ref id="B3-polymers-17-00485"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prinderre</surname><given-names>P.</given-names></name>
<name><surname>Sauzet</surname><given-names>C.</given-names></name>
<name><surname>Fuxen</surname><given-names>C.</given-names></name>
</person-group><article-title>Advances in Gastro Retentive Drug-Delivery Systems</article-title><source>Expert Opin. Drug Deliv.</source><year>2011</year><volume>8</volume><fpage>1189</fpage><lpage>1203</lpage><pub-id pub-id-type="doi">10.1517/17425247.2011.592828</pub-id><pub-id pub-id-type="pmid">21671821</pub-id>
</element-citation></ref><ref id="B4-polymers-17-00485"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meka</surname><given-names>L.</given-names></name>
<name><surname>Kesavan</surname><given-names>B.</given-names></name>
<name><surname>Kalamata</surname><given-names>V.N.</given-names></name>
<name><surname>Eaga</surname><given-names>C.M.</given-names></name>
<name><surname>Bandari</surname><given-names>S.</given-names></name>
<name><surname>Vobalaboina</surname><given-names>V.</given-names></name>
<name><surname>Yamsani</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Design and Evaluation of Polymeric Coated Minitablets as Multiple Unit Gastroretentive Floating Drug Delivery Systems for Furosemide</article-title><source>J. Pharm. Sci.</source><year>2009</year><volume>98</volume><fpage>2122</fpage><lpage>2132</lpage><pub-id pub-id-type="doi">10.1002/jps.21562</pub-id><pub-id pub-id-type="pmid">19009598</pub-id>
</element-citation></ref><ref id="B5-polymers-17-00485"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sawicki</surname><given-names>W.</given-names></name>
</person-group><article-title>Pharmacokinetics of Verapamil and Norverapamil from Controlled Release Floating Pellets in Humans</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2002</year><volume>53</volume><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/S0939-6411(01)00189-8</pub-id><pub-id pub-id-type="pmid">11777750</pub-id>
</element-citation></ref><ref id="B6-polymers-17-00485"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jim&#x000e9;nez-Mart&#x000ed;nez</surname><given-names>I.</given-names></name>
<name><surname>Quirino-Barreda</surname><given-names>T.</given-names></name>
<name><surname>Villafuerte-Robles</surname><given-names>L.</given-names></name>
</person-group><article-title>Sustained Delivery of Captopril from Floating Matrix Tablets</article-title><source>Int. J. Pharm.</source><year>2008</year><volume>362</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2008.05.040</pub-id><pub-id pub-id-type="pmid">18588962</pub-id>
</element-citation></ref><ref id="B7-polymers-17-00485"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Odeku</surname><given-names>O.A.</given-names></name>
<name><surname>Aderogba</surname><given-names>A.A.</given-names></name>
<name><surname>Ajala</surname><given-names>T.O.</given-names></name>
<name><surname>Akin-Ajani</surname><given-names>O.D.</given-names></name>
<name><surname>Okunlola</surname><given-names>A.</given-names></name>
</person-group><article-title>Formulation of Floating Metronidazole Microspheres Using Cassava Starch (Manihot Esculenta) as Polymer</article-title><source>J. Pharm. Investig.</source><year>2017</year><volume>47</volume><fpage>445</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1007/s40005-017-0319-7</pub-id></element-citation></ref><ref id="B8-polymers-17-00485"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hooda</surname><given-names>A.</given-names></name>
<name><surname>Nanda</surname><given-names>A.</given-names></name>
<name><surname>Jain</surname><given-names>M.</given-names></name>
<name><surname>Kumar</surname><given-names>V.</given-names></name>
<name><surname>Rathee</surname><given-names>P.</given-names></name>
</person-group><article-title>Optimization and Evaluation of Gastroretentive Ranitidine HCl Microspheres by Using Design Expert Software</article-title><source>Int. J. Biol. Macromol.</source><year>2012</year><volume>51</volume><fpage>691</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2012.07.030</pub-id><pub-id pub-id-type="pmid">22903013</pub-id>
</element-citation></ref><ref id="B9-polymers-17-00485"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tripathi</surname><given-names>J.</given-names></name>
<name><surname>Thapa</surname><given-names>P.</given-names></name>
<name><surname>Maharjan</surname><given-names>R.</given-names></name>
<name><surname>Jeong</surname><given-names>S.H.</given-names></name>
</person-group><article-title>Current State and Future Perspectives on Gastroretentive Drug Delivery Systems</article-title><source>Pharmaceutics</source><year>2019</year><volume>11</volume><elocation-id>193</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics11040193</pub-id><pub-id pub-id-type="pmid">31010054</pub-id>
</element-citation></ref><ref id="B10-polymers-17-00485"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chawla</surname><given-names>G.</given-names></name>
<name><surname>Bansal</surname><given-names>A.</given-names></name>
</person-group><article-title>A Means to Address Regional Variability in Intestinal Drug Absorption</article-title><source>PharmTech</source><year>2003</year><volume>27</volume><fpage>50</fpage><lpage>68</lpage></element-citation></ref><ref id="B11-polymers-17-00485"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Awasthi</surname><given-names>R.</given-names></name>
<name><surname>Kulkarni</surname><given-names>G.T.</given-names></name>
</person-group><article-title>Decades of Research in Drug Targeting to the Upper Gastrointestinal Tract Using Gastroretention Technologies: Where Do We Stand?</article-title><source>Drug Deliv.</source><year>2016</year><volume>23</volume><fpage>378</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.3109/10717544.2014.936535</pub-id><pub-id pub-id-type="pmid">25026414</pub-id>
</element-citation></ref><ref id="B12-polymers-17-00485"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bardonnet</surname><given-names>P.L.</given-names></name>
<name><surname>Faivre</surname><given-names>V.</given-names></name>
<name><surname>Pugh</surname><given-names>W.J.</given-names></name>
<name><surname>Piffaretti</surname><given-names>J.C.</given-names></name>
<name><surname>Falson</surname><given-names>F.</given-names></name>
</person-group><article-title>Gastroretentive Dosage Forms: Overview and Special Case of Helicobacter Pylori</article-title><source>J. Control. Release</source><year>2006</year><volume>111</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2005.10.031</pub-id><pub-id pub-id-type="pmid">16403588</pub-id>
</element-citation></ref><ref id="B13-polymers-17-00485"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Streubel</surname><given-names>A.</given-names></name>
<name><surname>Siepmann</surname><given-names>J.</given-names></name>
<name><surname>Bodmeier</surname><given-names>R.</given-names></name>
</person-group><article-title>Drug Delivery to the Upper Small Intestine Window Using Gastroretentive Technologies</article-title><source>Curr. Opin. Pharmacol.</source><year>2006</year><volume>6</volume><fpage>501</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2006.04.007</pub-id><pub-id pub-id-type="pmid">16890020</pub-id>
</element-citation></ref><ref id="B14-polymers-17-00485"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oh</surname><given-names>T.O.</given-names></name>
<name><surname>Kim</surname><given-names>J.Y.</given-names></name>
<name><surname>Ha</surname><given-names>J.M.</given-names></name>
<name><surname>Chi</surname><given-names>S.C.</given-names></name>
<name><surname>Rhee</surname><given-names>Y.S.</given-names></name>
<name><surname>Park</surname><given-names>C.W.</given-names></name>
<name><surname>Park</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Preparation of Highly Porous Gastroretentive Metformin Tablets Using a Sublimation Method</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2013</year><volume>83</volume><fpage>460</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2012.11.009</pub-id><pub-id pub-id-type="pmid">23246798</pub-id>
</element-citation></ref><ref id="B15-polymers-17-00485"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Simons</surname><given-names>F.J.</given-names></name>
<name><surname>Wagner</surname><given-names>K.G.</given-names></name>
</person-group><article-title>Modeling, Design and Manufacture of Innovative Floating Gastroretentive Drug Delivery Systems Based on Hot-Melt Extruded Tubes</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2019</year><volume>137</volume><fpage>196</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2019.02.022</pub-id><pub-id pub-id-type="pmid">30826475</pub-id>
</element-citation></ref><ref id="B16-polymers-17-00485"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vo</surname><given-names>A.Q.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Nyavanandi</surname><given-names>D.</given-names></name>
<name><surname>Bandari</surname><given-names>S.</given-names></name>
<name><surname>Repka</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Hot Melt Extrusion Paired Fused Deposition Modeling 3D Printing to Develop Hydroxypropyl Cellulose Based Floating Tablets of Cinnarizine</article-title><source>Carbohydr. Polym.</source><year>2020</year><volume>246</volume><fpage>116519</fpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2020.116519</pub-id><pub-id pub-id-type="pmid">32747229</pub-id>
</element-citation></ref><ref id="B17-polymers-17-00485"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dumpa</surname><given-names>N.R.</given-names></name>
<name><surname>Bandari</surname><given-names>S.</given-names></name>
<name><surname>Repka</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Novel Gastroretentive Floating Pulsatile Drug Delivery System Produced via Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing</article-title><source>Pharmaceutics</source><year>2020</year><volume>12</volume><elocation-id>52</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics12010052</pub-id><pub-id pub-id-type="pmid">31936212</pub-id>
</element-citation></ref><ref id="B18-polymers-17-00485"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Panraksa</surname><given-names>P.</given-names></name>
<name><surname>Hamdallah</surname><given-names>S.I.</given-names></name>
<name><surname>Yilmaz</surname><given-names>O.</given-names></name>
<name><surname>Saokham</surname><given-names>P.</given-names></name>
<name><surname>Rachtanapun</surname><given-names>P.</given-names></name>
<name><surname>Qi</surname><given-names>S.</given-names></name>
<name><surname>Jantrawut</surname><given-names>P.</given-names></name>
</person-group><article-title>4D Printing of Shape-Memory Polymer-Based Floating Tablets via Fused Deposition Modelling: Transformable Helical Structure to Tablet-like Form</article-title><source>J. Drug Deliv. Sci. Technol.</source><year>2024</year><volume>104</volume><fpage>106534</fpage><pub-id pub-id-type="doi">10.1016/j.jddst.2024.106534</pub-id></element-citation></ref><ref id="B19-polymers-17-00485"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>C.</given-names></name>
<name><surname>Yu</surname><given-names>C.</given-names></name>
<name><surname>Cui</surname><given-names>L.</given-names></name>
<name><surname>Song</surname><given-names>Z.</given-names></name>
<name><surname>Zhao</surname><given-names>X.</given-names></name>
<name><surname>Ma</surname><given-names>Y.</given-names></name>
<name><surname>Jiang</surname><given-names>L.</given-names></name>
</person-group><article-title>Facile Preparation of the Porous PDMS Oil-Absorbent for Oil/Water Separation</article-title><source>Adv. Mater. Interfaces</source><year>2017</year><volume>4</volume><fpage>1600862</fpage><pub-id pub-id-type="doi">10.1002/admi.201600862</pub-id></element-citation></ref><ref id="B20-polymers-17-00485"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cha</surname><given-names>K.J.</given-names></name>
<name><surname>Kim</surname><given-names>D.S.</given-names></name>
</person-group><article-title>A Portable Pressure Pump for Microfluidic Lab-on-a-Chip Systems Using a Porous Polydimethylsiloxane (PDMS) Sponge</article-title><source>Biomed. Microdevices</source><year>2011</year><volume>13</volume><fpage>877</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1007/s10544-011-9557-z</pub-id><pub-id pub-id-type="pmid">21698383</pub-id>
</element-citation></ref><ref id="B21-polymers-17-00485"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Crook</surname><given-names>J.M.</given-names></name>
<name><surname>Wallace</surname><given-names>G.G.</given-names></name>
</person-group><article-title>Development of a Porous 3D Graphene-PDMS Scaffold for Improved Osseointegration</article-title><source>Colloids Surf. B Biointerfaces</source><year>2017</year><volume>159</volume><fpage>386</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2017.07.087</pub-id><pub-id pub-id-type="pmid">28818783</pub-id>
</element-citation></ref><ref id="B22-polymers-17-00485"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gonz&#x000e1;lez-Rivera</surname><given-names>J.</given-names></name>
<name><surname>Iglio</surname><given-names>R.</given-names></name>
<name><surname>Barillaro</surname><given-names>G.</given-names></name>
<name><surname>Duce</surname><given-names>C.</given-names></name>
<name><surname>Tin&#x000e8;</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Structural and Thermoanalytical Characterization of 3D Porous PDMS Foam Materials: The Effect of Impurities Derived from a Sugar Templating Process</article-title><source>Polymers</source><year>2018</year><volume>10</volume><elocation-id>616</elocation-id><pub-id pub-id-type="doi">10.3390/polym10060616</pub-id><pub-id pub-id-type="pmid">30966650</pub-id>
</element-citation></ref><ref id="B23-polymers-17-00485"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Worajittiphon</surname><given-names>P.</given-names></name>
<name><surname>Majan</surname><given-names>P.</given-names></name>
<name><surname>Wangkawong</surname><given-names>K.</given-names></name>
<name><surname>Somsunan</surname><given-names>R.</given-names></name>
<name><surname>Jantrawut</surname><given-names>P.</given-names></name>
<name><surname>Panraksa</surname><given-names>P.</given-names></name>
<name><surname>Chaiwarit</surname><given-names>T.</given-names></name>
<name><surname>Srithep</surname><given-names>Y.</given-names></name>
<name><surname>Sommano</surname><given-names>S.R.</given-names></name>
<name><surname>Jantanasakulwong</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Inside-out Templating: A Strategy to Decorate Helical Carbon Nanotubes and 2D MoS2 on Ethyl Cellulose Sponge for Enhanced Oil Adsorption and Oil/Water Separation</article-title><source>Int. J. Biol. Macromol.</source><year>2024</year><volume>273</volume><elocation-id>133119</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.133119</pub-id><pub-id pub-id-type="pmid">38880452</pub-id>
</element-citation></ref><ref id="B24-polymers-17-00485"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ahmadi</surname><given-names>P.</given-names></name>
<name><surname>Jahanban-Esfahlan</surname><given-names>A.</given-names></name>
<name><surname>Ahmadi</surname><given-names>A.</given-names></name>
<name><surname>Tabibiazar</surname><given-names>M.</given-names></name>
<name><surname>Mohammadifar</surname><given-names>M.</given-names></name>
</person-group><article-title>Development of Ethyl Cellulose-Based Formulations: A Perspective on the Novel Technical Methods</article-title><source>Food Rev. Int.</source><year>2022</year><volume>38</volume><fpage>685</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1080/87559129.2020.1741007</pub-id></element-citation></ref><ref id="B25-polymers-17-00485"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arca</surname><given-names>H.C.</given-names></name>
<name><surname>Mosquera-Giraldo</surname><given-names>L.I.</given-names></name>
<name><surname>Bi</surname><given-names>V.</given-names></name>
<name><surname>Xu</surname><given-names>D.</given-names></name>
<name><surname>Taylor</surname><given-names>L.S.</given-names></name>
<name><surname>Edgar</surname><given-names>K.J.</given-names></name>
</person-group><article-title>Pharmaceutical Applications of Cellulose Ethers and Cellulose Ether Esters</article-title><source>Biomacromolecules</source><year>2018</year><volume>19</volume><fpage>2351</fpage><lpage>2376</lpage><pub-id pub-id-type="doi">10.1021/acs.biomac.8b00517</pub-id><pub-id pub-id-type="pmid">29869877</pub-id>
</element-citation></ref><ref id="B26-polymers-17-00485"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qin</surname><given-names>Z.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
</person-group><article-title>Synergistic Action of Famotidine and Chlorpheniramine on Acetic Acid-Induced Chronic Gastric Ulcer in Rats</article-title><source>World J. Gastroenterol.</source><year>2005</year><volume>11</volume><fpage>7203</fpage><lpage>7207</lpage><pub-id pub-id-type="doi">10.3748/wjg.v11.i45.7203</pub-id><pub-id pub-id-type="pmid">16437673</pub-id>
</element-citation></ref><ref id="B27-polymers-17-00485"><label>27.</label><element-citation publication-type="book"><article-title>Dragonfly 2024.1 [Computer Software]</article-title><publisher-name>Comet Technologies Canada Inc.</publisher-name><publisher-loc>Montreal, Canada</publisher-loc><comment>Available online: <ext-link xlink:href="https://dragonfly.comet.tech/" ext-link-type="uri">https://dragonfly.comet.tech/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-31">(accessed on 31 December 2024)</date-in-citation></element-citation></ref><ref id="B28-polymers-17-00485"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thapa</surname><given-names>P.</given-names></name>
<name><surname>Lee</surname><given-names>A.R.</given-names></name>
<name><surname>Choi</surname><given-names>D.H.</given-names></name>
<name><surname>Jeong</surname><given-names>S.H.</given-names></name>
</person-group><article-title>Effects of Moisture Content and Compression Pressure of Various Deforming Granules on the Physical Properties of Tablets</article-title><source>Powder Technol.</source><year>2017</year><volume>310</volume><fpage>92</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.powtec.2017.01.021</pub-id></element-citation></ref><ref id="B29-polymers-17-00485"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farias</surname><given-names>S.</given-names></name>
<name><surname>Boateng</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Development and Functional Characterization of Composite Freeze Dried Wafers for Potential Delivery of Low Dose Aspirin for Elderly People with Dysphagia</article-title><source>Int. J. Pharm.</source><year>2018</year><volume>553</volume><fpage>65</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2018.10.025</pub-id><pub-id pub-id-type="pmid">30312748</pub-id>
</element-citation></ref><ref id="B30-polymers-17-00485"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nigusse</surname><given-names>B.</given-names></name>
<name><surname>Gebre-Mariam</surname><given-names>T.</given-names></name>
<name><surname>Belete</surname><given-names>A.</given-names></name>
</person-group><article-title>Design, Development and Optimization of Sustained Release Floating, Bioadhesive and Swellable Matrix Tablet of Ranitidine Hydrochloride</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><elocation-id>e0253391</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0253391</pub-id><pub-id pub-id-type="pmid">34170952</pub-id>
</element-citation></ref><ref id="B31-polymers-17-00485"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>Monograph: USP</collab>
</person-group><article-title>Chlorpheniramine Maleate Tablets</article-title><source>The United States Pharmacopeia (USP43 NF38)</source><publisher-name>The United States Pharmacopeial Convention</publisher-name><publisher-loc>Rockville, MD, USA</publisher-loc><year>2019</year><fpage>971</fpage></element-citation></ref><ref id="B32-polymers-17-00485"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prasanthi</surname><given-names>I.</given-names></name>
<name><surname>Datta</surname><given-names>K.K.R.</given-names></name>
</person-group><article-title>Super-Wetting Properties of Functionalized Fluorinated Graphene and Its Application in Oil&#x02013;Water and Emulsion Separation</article-title><source>Mater. Chem. Front.</source><year>2021</year><volume>5</volume><fpage>6244</fpage><lpage>6255</lpage><pub-id pub-id-type="doi">10.1039/D1QM00757B</pub-id></element-citation></ref><ref id="B33-polymers-17-00485"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valeveti</surname><given-names>S.K.</given-names></name>
<name><surname>Pashikanti</surname><given-names>S.</given-names></name>
</person-group><article-title>Design, Development, and Evaluation of Transdermal Patches Containing Memantine Hydrochloride</article-title><source>Int. J. Appl. Pharm.</source><year>2023</year><volume>15</volume><fpage>181</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.22159/ijap.2023v15i5.48481</pub-id></element-citation></ref><ref id="B34-polymers-17-00485"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oh</surname><given-names>M.J.</given-names></name>
<name><surname>Oh</surname><given-names>J.H.</given-names></name>
<name><surname>Lee</surname><given-names>E.K.</given-names></name>
</person-group><article-title>Hybrid Amphiphilic Janus PDMS Sponge Enabling Electrical Sensing of Organic Solvents</article-title><source>Sensors Actuators A Phys.</source><year>2024</year><volume>378</volume><fpage>115783</fpage><pub-id pub-id-type="doi">10.1016/j.sna.2024.115783</pub-id></element-citation></ref><ref id="B35-polymers-17-00485"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saur&#x000ed;</surname><given-names>J.</given-names></name>
<name><surname>Zachariah</surname><given-names>M.</given-names></name>
<name><surname>Macovez</surname><given-names>R.</given-names></name>
<name><surname>Tamarit</surname><given-names>J.L.</given-names></name>
<name><surname>Mill&#x000e1;n</surname><given-names>D.</given-names></name>
<name><surname>Su&#x000f1;&#x000e9;-Pou</surname><given-names>M.</given-names></name>
<name><surname>Garc&#x000ed;a-Montoya</surname><given-names>E.</given-names></name>
<name><surname>P&#x000e9;rez-Lozano</surname><given-names>P.</given-names></name>
<name><surname>Mi&#x000f1;arro</surname><given-names>M.</given-names></name>
<name><surname>Tic&#x000f3;</surname><given-names>J.R.</given-names></name>
<etal/>
</person-group><article-title>Formulation and Characterization of Mucoadhesive Controlled Release Matrix Tablets of Captopril</article-title><source>J. Drug Deliv. Sci. Technol.</source><year>2017</year><volume>42</volume><fpage>215</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.jddst.2017.03.009</pub-id></element-citation></ref><ref id="B36-polymers-17-00485"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>M.</given-names></name>
<name><surname>Tie</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>G.</given-names></name>
</person-group><article-title>Shrinkage Properties of Porous Materials during Drying: A Review</article-title><source>Front. Mater.</source><year>2024</year><volume>11</volume><elocation-id>1330599</elocation-id><pub-id pub-id-type="doi">10.3389/fmats.2024.1330599</pub-id></element-citation></ref><ref id="B37-polymers-17-00485"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ozkan</surname><given-names>E.</given-names></name>
<name><surname>Garren</surname><given-names>M.</given-names></name>
<name><surname>Manuel</surname><given-names>J.</given-names></name>
<name><surname>Douglass</surname><given-names>M.</given-names></name>
<name><surname>Devine</surname><given-names>R.</given-names></name>
<name><surname>Mondal</surname><given-names>A.</given-names></name>
<name><surname>Kumar</surname><given-names>A.</given-names></name>
<name><surname>Ashcraft</surname><given-names>M.</given-names></name>
<name><surname>Pandey</surname><given-names>R.</given-names></name>
<name><surname>Handa</surname><given-names>H.</given-names></name>
</person-group><article-title>Superhydrophobic and Conductive Foams with Antifouling and Oil-Water Separation Properties</article-title><source>ACS Appl. Mater. Interfaces</source><year>2023</year><volume>15</volume><fpage>7610</fpage><lpage>7626</lpage><pub-id pub-id-type="doi">10.1021/acsami.2c22180</pub-id><pub-id pub-id-type="pmid">36700859</pub-id>
</element-citation></ref><ref id="B38-polymers-17-00485"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McGuckin</surname><given-names>J.F.</given-names></name>
<name><surname>Akhtar</surname><given-names>N.</given-names></name>
<name><surname>Ho</surname><given-names>V.T.</given-names></name>
<name><surname>Smergel</surname><given-names>E.M.</given-names></name>
<name><surname>Kubacki</surname><given-names>E.J.</given-names></name>
<name><surname>Villafana</surname><given-names>T.</given-names></name>
</person-group><article-title>CT and MR Evaluation of a Wooden Foreign Body in an in Vitro Model of the Orbit</article-title><source>Am. J. Neuroradiol.</source><year>1996</year><volume>17</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">8770263</pub-id>
</element-citation></ref><ref id="B39-polymers-17-00485"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tseng</surname><given-names>H.J.</given-names></name>
<name><surname>Hanna</surname><given-names>T.N.</given-names></name>
<name><surname>Shuaib</surname><given-names>W.</given-names></name>
<name><surname>Aized</surname><given-names>M.</given-names></name>
<name><surname>Khosa</surname><given-names>F.</given-names></name>
<name><surname>Linnau</surname><given-names>K.F.</given-names></name>
</person-group><article-title>Imaging Foreign Bodies: Ingested, Aspirated, and Inserted Presented at the American Roentgen Ray Society Annual Meeting, Toronto, Ontario, Canada, April 2015</article-title><source>Ann. Emerg. Med.</source><year>2015</year><volume>66</volume><fpage>570</fpage><lpage>582.e5</lpage><pub-id pub-id-type="doi">10.1016/j.annemergmed.2015.07.499</pub-id><pub-id pub-id-type="pmid">26320521</pub-id>
</element-citation></ref><ref id="B40-polymers-17-00485"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Freag</surname><given-names>M.S.</given-names></name>
<name><surname>Saleh</surname><given-names>W.M.</given-names></name>
<name><surname>Abdallah</surname><given-names>O.Y.</given-names></name>
</person-group><article-title>Exploiting Polymer Blending Approach for Fabrication of Buccal Chitosan-Based Composite Sponges with Augmented Mucoadhesive Characteristics</article-title><source>Eur. J. Pharm. Sci.</source><year>2018</year><volume>120</volume><fpage>10</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2018.04.041</pub-id><pub-id pub-id-type="pmid">29715500</pub-id>
</element-citation></ref><ref id="B41-polymers-17-00485"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pitt</surname><given-names>K.G.</given-names></name>
<name><surname>Heasley</surname><given-names>M.G.</given-names></name>
</person-group><article-title>Determination of the Tensile Strength of Elongated Tablets</article-title><source>Powder Technol.</source><year>2013</year><volume>238</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.powtec.2011.12.060</pub-id></element-citation></ref><ref id="B42-polymers-17-00485"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pitt</surname><given-names>K.G.</given-names></name>
<name><surname>Webber</surname><given-names>R.J.</given-names></name>
<name><surname>Hill</surname><given-names>K.A.</given-names></name>
<name><surname>Dey</surname><given-names>D.</given-names></name>
<name><surname>Gamlen</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Compression Prediction Accuracy from Small Scale Compaction Studies to Production Presses</article-title><source>Powder Technol.</source><year>2015</year><volume>270</volume><fpage>490</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1016/j.powtec.2013.10.007</pub-id></element-citation></ref><ref id="B43-polymers-17-00485"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>C.C.</given-names></name>
</person-group><article-title>Microstructure of Tablet&#x02014;Pharmaceutical Significance, Assessment, and Engineering</article-title><source>Pharm. Res.</source><year>2017</year><volume>34</volume><fpage>918</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1007/s11095-016-1989-y</pub-id><pub-id pub-id-type="pmid">27380192</pub-id>
</element-citation></ref><ref id="B44-polymers-17-00485"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Teixeira</surname><given-names>M.T.</given-names></name>
<name><surname>Sa-Barreto</surname><given-names>L.L.</given-names></name>
<name><surname>Silva</surname><given-names>I.C.</given-names></name>
<name><surname>Gratieri</surname><given-names>T.</given-names></name>
<name><surname>Gelfuso</surname><given-names>G.M.</given-names></name>
<name><surname>Marreto</surname><given-names>R.N.</given-names></name>
<name><surname>Landin</surname><given-names>M.</given-names></name>
<name><surname>Cunha-Filho</surname><given-names>M.</given-names></name>
</person-group><article-title>The Influence of Porosity on Tablet Subdivision</article-title><source>Particuology</source><year>2020</year><volume>53</volume><fpage>192</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.partic.2020.06.001</pub-id></element-citation></ref><ref id="B45-polymers-17-00485"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rossi</surname><given-names>S.</given-names></name>
<name><surname>Marciello</surname><given-names>M.</given-names></name>
<name><surname>Ferrari</surname><given-names>F.</given-names></name>
<name><surname>Puccio</surname><given-names>A.</given-names></name>
<name><surname>Bonferoni</surname><given-names>C.</given-names></name>
<name><surname>Sandri</surname><given-names>G.</given-names></name>
<name><surname>Caramella</surname><given-names>C.</given-names></name>
</person-group><article-title>Development of Sponge-like Dressings for Mucosal/Transmucosal Drug Delivery into Vaginal Cavity</article-title><source>Pharm. Dev. Technol.</source><year>2012</year><volume>17</volume><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.3109/10837450.2010.531736</pub-id><pub-id pub-id-type="pmid">21077750</pub-id>
</element-citation></ref><ref id="B46-polymers-17-00485"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aliasgharlou</surname><given-names>N.</given-names></name>
<name><surname>Asghari Sana</surname><given-names>F.</given-names></name>
<name><surname>Khoshbakht</surname><given-names>S.</given-names></name>
<name><surname>Zolfaghari</surname><given-names>P.</given-names></name>
<name><surname>Charkhian</surname><given-names>H.</given-names></name>
</person-group><article-title>Fabrication and Characterization of Boric Acid-Crosslinked Ethyl Cellulose and Polyvinyl Alcohol Films as Potential Drug Release Systems for Topical Drug Delivery</article-title><source>Turkish J. Chem.</source><year>2020</year><volume>44</volume><fpage>1723</fpage><lpage>1732</lpage><pub-id pub-id-type="doi">10.3906/kim-2008-23</pub-id></element-citation></ref><ref id="B47-polymers-17-00485"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>S&#x000e1;nchez-Lafuente</surname><given-names>C.</given-names></name>
<name><surname>Teresa Faucci</surname><given-names>M.</given-names></name>
<name><surname>Fern&#x000e1;ndez-Ar&#x000e9;valo</surname><given-names>M.</given-names></name>
<name><surname>&#x000c1;lvarez-Fuentes</surname><given-names>J.</given-names></name>
<name><surname>Rabasco</surname><given-names>A.M.</given-names></name>
<name><surname>Mura</surname><given-names>P.</given-names></name>
</person-group><article-title>Development of Sustained Release Matrix Tablets of Didanosine Containing Methacrylic and Ethylcellulose Polymers</article-title><source>Int. J. Pharm.</source><year>2002</year><volume>234</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/S0378-5173(01)00962-0</pub-id><pub-id pub-id-type="pmid">11839452</pub-id>
</element-citation></ref><ref id="B48-polymers-17-00485"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El-Bagory</surname><given-names>I.</given-names></name>
<name><surname>Barakat</surname><given-names>N.</given-names></name>
<name><surname>Ibrahim</surname><given-names>M.A.</given-names></name>
<name><surname>El-Enazi</surname><given-names>F.</given-names></name>
</person-group><article-title>Formulation and in Vitro Evaluation of Theophylline Matrix Tablets Prepared by Direct Compression: Effect of Polymer Blends</article-title><source>Saudi Pharm. J.</source><year>2012</year><volume>20</volume><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2011.11.007</pub-id><pub-id pub-id-type="pmid">24115902</pub-id>
</element-citation></ref><ref id="B49-polymers-17-00485"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>T.</given-names></name>
<name><surname>Van Colen</surname><given-names>G.</given-names></name>
<name><surname>Sander</surname><given-names>B.</given-names></name>
<name><surname>Golas</surname><given-names>M.M.</given-names></name>
<name><surname>Uezguen</surname><given-names>S.</given-names></name>
<name><surname>Weigandt</surname><given-names>M.</given-names></name>
<name><surname>Goepferich</surname><given-names>A.</given-names></name>
</person-group><article-title>Drug Loading of Polymeric Micelles</article-title><source>Pharm. Res.</source><year>2013</year><volume>30</volume><fpage>584</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1007/s11095-012-0903-5</pub-id><pub-id pub-id-type="pmid">23135819</pub-id>
</element-citation></ref><ref id="B50-polymers-17-00485"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gurikov</surname><given-names>P.</given-names></name>
<name><surname>Smirnova</surname><given-names>I.</given-names></name>
</person-group><article-title>Amorphization of Drugs by Adsorptive Precipitation from Supercritical Solutions: A Review</article-title><source>J. Supercrit. Fluids</source><year>2018</year><volume>132</volume><fpage>105</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.supflu.2017.03.005</pub-id></element-citation></ref><ref id="B51-polymers-17-00485"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>F.</given-names></name>
</person-group><article-title>Physicochemical Properties and Mechanisms of Drug Release from Melt-Extruded Granules Consisting of Chlorpheniramine Maleate and Eudragit FS</article-title><source>Drug Dev. Ind. Pharm.</source><year>2016</year><volume>42</volume><fpage>563</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.3109/03639045.2015.1054832</pub-id><pub-id pub-id-type="pmid">26065535</pub-id>
</element-citation></ref><ref id="B52-polymers-17-00485"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Timmermans</surname><given-names>J.</given-names></name>
<name><surname>Mo&#x000eb;s</surname><given-names>A.J.</given-names></name>
</person-group><article-title>How Well Do Floating Dosage Forms Float?</article-title><source>Int. J. Pharm.</source><year>1990</year><volume>62</volume><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/0378-5173(90)90234-U</pub-id></element-citation></ref><ref id="B53-polymers-17-00485"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chauhan</surname><given-names>M.S.</given-names></name>
<name><surname>Kumar</surname><given-names>A.</given-names></name>
<name><surname>Pathak</surname><given-names>K.</given-names></name>
</person-group><article-title>Osmotically Regulated Floating Asymmetric Membrane Capsule for Controlled Site-Specific Delivery of Ranitidine Hydrochloride: Optimization by Central Composite Design</article-title><source>AAPS PharmSciTech</source><year>2012</year><volume>13</volume><fpage>1492</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.1208/s12249-012-9870-8</pub-id><pub-id pub-id-type="pmid">23104305</pub-id>
</element-citation></ref><ref id="B54-polymers-17-00485"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Ou</surname><given-names>Z.</given-names></name>
<name><surname>Yang</surname><given-names>G.</given-names></name>
</person-group><article-title>3D Printed Tablets with Internal Scaffold Structure Using Ethyl Cellulose to Achieve Sustained Ibuprofen Release</article-title><source>Eur. J. Pharm. Sci.</source><year>2018</year><volume>115</volume><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2018.01.005</pub-id><pub-id pub-id-type="pmid">29305984</pub-id>
</element-citation></ref><ref id="B55-polymers-17-00485"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Quinten</surname><given-names>T.</given-names></name>
<name><surname>Beer</surname><given-names>T.D.</given-names></name>
<name><surname>Vervaet</surname><given-names>C.</given-names></name>
<name><surname>Remon</surname><given-names>J.P.</given-names></name>
</person-group><article-title>Evaluation of Injection Moulding as a Pharmaceutical Technology to Produce Matrix Tablets</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2009</year><volume>71</volume><fpage>145</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2008.02.025</pub-id><pub-id pub-id-type="pmid">18511248</pub-id>
</element-citation></ref><ref id="B56-polymers-17-00485"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peppas</surname><given-names>N.A.</given-names></name>
</person-group><article-title>Analysis of Fickian and Non-Fickian Drug Release from Polymers</article-title><source>Pharm. Acta Helv.</source><year>1985</year><volume>60</volume><fpage>110</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">4011621</pub-id>
</element-citation></ref><ref id="B57-polymers-17-00485"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hafeez</surname><given-names>A.</given-names></name>
<name><surname>Razvi</surname><given-names>N.</given-names></name>
<name><surname>Talib</surname><given-names>N.</given-names></name>
<name><surname>Ghayas</surname><given-names>S.</given-names></name>
<name><surname>Anjum</surname><given-names>F.</given-names></name>
<name><surname>Bushra</surname><given-names>R.</given-names></name>
</person-group><article-title>Formulation Optimization, in Vitro Characterization and Stability Studies of Sustain Release Tablets of Ketoprofen</article-title><source>Pak. J. Pharm. Sci.</source><year>2019</year><volume>32</volume><fpage>1245</fpage><lpage>1251</lpage><pub-id pub-id-type="pmid">31303597</pub-id>
</element-citation></ref><ref id="B58-polymers-17-00485"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ahmed</surname><given-names>L.</given-names></name>
<name><surname>Atif</surname><given-names>R.</given-names></name>
<name><surname>Salah Eldeen</surname><given-names>T.</given-names></name>
<name><surname>Yahya</surname><given-names>I.</given-names></name>
<name><surname>Omara</surname><given-names>A.</given-names></name>
<name><surname>Eltayeb</surname><given-names>M.</given-names></name>
</person-group><article-title>Study the Using of Nanoparticles as Drug Delivery System Based on Mathematical Models for Controlled Release</article-title><source>Int. J. Latest Technol. Eng.</source><year>2019</year><volume>8</volume><fpage>52</fpage><lpage>56</lpage></element-citation></ref><ref id="B59-polymers-17-00485"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fosca</surname><given-names>M.</given-names></name>
<name><surname>Rau</surname><given-names>J.V.</given-names></name>
<name><surname>Uskokovi&#x00107;</surname><given-names>V.</given-names></name>
</person-group><article-title>Factors Influencing the Drug Release from Calcium Phosphate Cements</article-title><source>Bioact. Mater.</source><year>2022</year><volume>7</volume><fpage>341</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.bioactmat.2021.05.032</pub-id><pub-id pub-id-type="pmid">34466737</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="polymers-17-00485-f001"><label>Figure 1</label><caption><p>Schematic design of PDMS tablet molds.</p></caption><graphic xlink:href="polymers-17-00485-g001" position="float"/></fig><fig position="float" id="polymers-17-00485-f002"><label>Figure 2</label><caption><p>(<bold>a</bold>) Moist sugar pressed into molds; (<bold>b</bold>) sugar tablet templates after drying.</p></caption><graphic xlink:href="polymers-17-00485-g002" position="float"/></fig><fig position="float" id="polymers-17-00485-f003"><label>Figure 3</label><caption><p>Cross-sectional images of cellulose derivative-based floating tablet formulations: (<bold>a</bold>) EC-only formulation, (<bold>b</bold>) EC with 5% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> HPMC, and (<bold>c</bold>) EC with 7.5% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> HPMC.</p></caption><graphic xlink:href="polymers-17-00485-g003" position="float"/></fig><fig position="float" id="polymers-17-00485-f004"><label>Figure 4</label><caption><p>Cross-sectional images of drug-loaded floating tablets.</p></caption><graphic xlink:href="polymers-17-00485-g004" position="float"/></fig><fig position="float" id="polymers-17-00485-f005"><label>Figure 5</label><caption><p>X-ray micro-CT images showing full and cross-sectional views of (<bold>a</bold>) E<sub>10</sub>/CPM and (<bold>b</bold>) E<sub>10</sub>H<sub>5</sub>/CPM floating tablets.</p></caption><graphic xlink:href="polymers-17-00485-g005" position="float"/></fig><fig position="float" id="polymers-17-00485-f006"><label>Figure 6</label><caption><p><italic toggle="yes">In vitro</italic> CPM release profiles of E<sub>10</sub>/CPM and E<sub>10</sub>H<sub>5</sub>/CPM floating tablets over 72 h (<bold>a</bold>) and the first 6 h (<bold>b</bold>).</p></caption><graphic xlink:href="polymers-17-00485-g006" position="float"/></fig><table-wrap position="float" id="polymers-17-00485-t001"><object-id pub-id-type="pii">polymers-17-00485-t001_Table 1</object-id><label>Table 1</label><caption><p>Composition of cellulose derivative-based floating tablets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Formulation Code</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EC (% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HPMC E5 (% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Acetone (qs. to %)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>7.5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>10</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">10.0</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>12.5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">12.5</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>15</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">15.0</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>7.5</sub>H<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>10</sub>H<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">10.0</td><td align="center" valign="middle" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>12.5</sub>H<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">12.5</td><td align="center" valign="middle" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>15</sub>H<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">15.0</td><td align="center" valign="middle" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>7.5</sub>H<sub>7.5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>10</sub>H<sub>7.5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">10.0</td><td align="center" valign="middle" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>12.5</sub>H<sub>7.5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">12.5</td><td align="center" valign="middle" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E<sub>15</sub>H<sub>7.5</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td></tr></tbody></table></table-wrap><table-wrap position="float" id="polymers-17-00485-t002"><object-id pub-id-type="pii">polymers-17-00485-t002_Table 2</object-id><label>Table 2</label><caption><p>Physical properties of drug-loaded floating tablets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Formulation Code</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Weight<break/>(mg &#x000b1; SD)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Diameter<break/>(mm &#x000b1; SD)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Thickness<break/>(mm &#x000b1; SD)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Density<break/>(g/cm<sup>3</sup> &#x000b1; SD)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>10</sub>/CPM</td><td align="center" valign="middle" rowspan="1" colspan="1">39.93 &#x000b1; 0.25 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12.23 &#x000b1; 0.04 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.30 &#x000b1; 0.16 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.079 &#x000b1; 0.003 <sup>a</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E<sub>10</sub>H<sub>5</sub>/CPM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.40 &#x000b1; 3.69 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.43 &#x000b1; 0.08 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.39 &#x000b1; 0.14 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.095 &#x000b1; 0.010 <sup>b</sup></td></tr></tbody></table><table-wrap-foot><fn><p>For each test, average values with the same letter are not significantly different. Thus, average values with the different letters, e.g., &#x02018;a&#x02019; or &#x02018;b&#x02019;, are statistically different (<italic toggle="yes">p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="polymers-17-00485-t003"><object-id pub-id-type="pii">polymers-17-00485-t003_Table 3</object-id><label>Table 3</label><caption><p>Mechanical strength, floating behavior, and CPM loading content of drug-loaded floating tablets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Formulation Code</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Radial Tensile Strength<break/>(MPa &#x000b1; SD)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CPM Loading Content<break/>(mg &#x000b1; SD)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Floating Lag Time (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Floating Time (h)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>10</sub>/CPM</td><td align="center" valign="middle" rowspan="1" colspan="1">0.143 &#x000b1; 0.045 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.72 &#x000b1; 0.53 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;24</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E<sub>10</sub>H<sub>5</sub>/CPM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.156 &#x000b1; 0.004 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.40 &#x000b1; 0.22 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;24</td></tr></tbody></table><table-wrap-foot><fn><p>For each test, average values with the same letter are not significantly different. Thus, average values with the different letters, e.g., &#x02018;a&#x02019; or &#x02018;b&#x02019;, are statistically different (<italic toggle="yes">p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="polymers-17-00485-t004"><object-id pub-id-type="pii">polymers-17-00485-t004_Table 4</object-id><label>Table 4</label><caption><p>Release kinetic data for drug-loaded floating tablets fitted to various mathematical models.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Kinetic Model</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Parameters</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Formulation Code</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E<sub>10</sub>/CPM</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E<sub>10</sub>H<sub>5</sub>/CPM</th></tr></thead><tbody><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Zero-order</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-formula>
<mml:math id="mm45" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9901</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9451</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-formula>
<mml:math id="mm46" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>&#x000a0;</mml:mo><mml:mo>(</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.73</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">First-order</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-formula>
<mml:math id="mm47" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9439</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8614</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-formula>
<mml:math id="mm48" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>&#x000a0;</mml:mo><mml:mo>(</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.17</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Higuchi matrix</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-formula>
<mml:math id="mm49" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9695</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9877</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-formula>
<mml:math id="mm50" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:mo>&#x000a0;</mml:mo><mml:mo>(</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.52</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.15</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Korsmeyer&#x02013;Peppas</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-formula>
<mml:math id="mm51" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9900</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9959</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-formula>
<mml:math id="mm52" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>&#x000a0;</mml:mo><mml:mo>(</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.60</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-formula>
<mml:math id="mm53" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.40</td></tr></tbody></table></table-wrap></floats-group></article>